Call for comprehensive inclusion of patient reported outcomes in cardiovascular clinical trials

Patient reported outcomes (PROs) should be comprehensively included in cardiovascular clinical trials using the best available tools, according to leading cardiologists and industry representatives in the Cardiovascular Round Table (CRT). All ESC guideline committees will now systematically consider PROs when making recommendations. Topics: Clinical pharmacology
Source: ESC News and Press - Category: Cardiology Source Type: news